We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

By MedImaging International staff writers
Posted on 03 Mar 2014
Print article
New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology.

A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are quantizations of electromagnetic and mechanical vibrations, respectively. Therefore, plasmons are collective oscillations of the free electron gas density, for example, at optical frequencies.

“Plasmonic nanostructures are of great current interest as chemical sensors, in vivo imaging agents, and for photothermal therapeutics,” explained David G. Cahill, a professor and head of the department of materials science and engineering at the University of Illinois at Urbana-Champaign (USA). “Applications in imaging and sensing typically involve the emission of light at a different wavelength than the excitation, or ‘secondary light emission.’ The interpretation of resonant secondary light emission in terms of fundamental processes has been controversial for 40 years. In this work, we point out that resonant electronic Raman scattering and resonant fluorescence may both be useful descriptions of the secondary emission. Better understanding of these principles and their limitations can result in improved biological and medical imaging modalities.”

Fluorescence is a comparatively familiar process by which light of one color or wavelength is absorbed by a material, such as an organic dye or a phosphor, and then light is emitted at a different color after a brief interval of time. In Raman scattering, the wavelength of light is shifted to a different color in an instantaneous scattering event. Raman scattering is not common in everyday life but is a critical tool of analytic chemistry.

“Light emission from plasmonic nanostructures at wavelengths shorter than the wavelength of pulsed laser excitation is typically described as the simultaneous absorption of two photons followed by fluorescence, which is used a lot in biological imaging,” explained Dr. Jingyu Huang, first author of the study, which was published online January 2014 in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). “However, we found that by modeling the emission as Raman scattering from electron-hole pairs can predict how the light emission depends on laser power, pulse duration, and wavelength. Since we understand more of the mechanism of this kind of light mission, we can help to design the biological and medical imaging experiments better, and at the same time we can also have more insight into the broad background of surface-enhanced Raman scattering, which is also related to this kind of light emission.”

Related Links:

University of Illinois at Urbana-Champaign

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
P20 Elite
Thyroid Shield
Standard Thyroid Shield
Portable X-Ray Unit
AJEX240H

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.